Stocks and Investing
Stocks and Investing
Thu, October 28, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, October 27, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Driscoll Maintained (ZNTL) at Buy with Increased Target to $89 on, Oct 27th, 2021
Robert Driscoll of Wedbush, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Increased Target from $65 to $89 on, Oct 27th, 2021.
Robert has made no other calls on ZNTL in the last 4 months.
There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Robert's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Robert
- Bradley Canino of "Stifel" Initiated at Strong Buy and Held Target at $84 on, Thursday, September 30th, 2021
- Matthew Biegler of "Oppenheimer" Initiated at Buy and Held Target at $90 on, Wednesday, September 29th, 2021
Contributing Sources